Showing all published months. Partner preview tables include up to 20 countries.
USD value by month, all available partner countries combined
Free partner preview shows up to 20 countries.
Total value across the selected data period
| Partner | Value | Share |
|---|---|---|
| India | $25.7M | 18.5% |
| Vietnam | $18.3M | 13.2% |
| Pakistan | $10.9M | 7.8% |
| Egypt | $10.1M | 7.2% |
| Thailand | $5.9M | 4.3% |
| Brazil | $5.6M | 4.0% |
| UAE | $5.1M | 3.7% |
| Argentina | $5M | 3.6% |
| Germany | $5M | 3.6% |
| Taiwan | $4.3M | 3.1% |
| Russia | $4M | 2.9% |
| Spain | $3.5M | 2.5% |
| Indonesia | $3.4M | 2.4% |
| Türkiye | $3.3M | 2.3% |
| Mexico | $3.2M | 2.3% |
| Bangladesh | $3.1M | 2.3% |
| Greece | $2.7M | 1.9% |
| Italy | $2.6M | 1.9% |
| Kazakhstan | $2.4M | 1.7% |
| Iran | $2.2M | 1.6% |
Availability is confirmed when the API response loads.
| Partner | Value | Share |
|---|---|---|
| Vietnam | $1.6M | 49.0% |
| Argentina | $369K | 11.5% |
| Pakistan | $282.7K | 8.8% |
| Brazil | $197.1K | 6.1% |
| India | $181.7K | 5.6% |
| Türkiye | $149.6K | 4.6% |
| Indonesia | $119.1K | 3.7% |
| Egypt | $102.9K | 3.2% |
| Portugal | $75K | 2.3% |
| Thailand | $54.4K | 1.7% |
| Iraq | $52.6K | 1.6% |
| Mexico | $36.8K | 1.1% |
| UAE | $20.4K | 0.6% |
| Russia | $2.8K | 0.1% |
| Year | Export value |
|---|---|
| 2021 | $19.5M |
| 2022 | $16.4M |
| 2023 | $25M |
| 2024 | $27.2M |
| 2025 | $28.7M |
| 2026 | $22.4M |
Public data shows up to 20 partner countries for this exact eight-digit customs code. Request all available partner-month rows in CSV or Excel.
HS 30032012 is also written 3003.20.12. Values are in USD; the public series does not report tonnes or kg. Product scope: Institutional or bulk-quantity medicines utilizing ceftazidime as the active antibiotic component are traded without measured retail packaging. The public page shows monthly export partner previews from official GACC customs statistics. Full partner-month rows are available through a scoped custom data request.
Source: China General Administration of Customs (GACC), cleaned and structured by China Data Portal.
Transformations: Values are presented as published by the source.
China Data Portal. "China Medicaments of ceftazidime, neither in measured doses nor in retail packings (HS 30032012) Export Data." https://chinadata.live/china-trade/hs8/30032012/
HS 30032012 is also written 3003.20.12. Values are in USD; the public series does not report tonnes or kg. Product scope: Institutional or bulk-quantity medicines utilizing ceftazidime as the active antibiotic component are traded without measured retail packaging. The public page shows monthly export partner previews from official GACC customs statistics. Full partner-month rows are available through a scoped custom data request.
Source: China General Administration of Customs (GACC), cleaned and structured by China Data Portal.
Transformations: Values are presented as published by the source.
China Data Portal. "China Medicaments of ceftazidime, neither in measured doses nor in retail packings (HS 30032012) Export Data." https://chinadata.live/china-trade/hs8/30032012/
China exported $34.4M of medicaments of ceftazidime, neither in measured doses nor in retail packings in the twelve months to July 2026, averaging $2.9M per month, based on official China customs statistics (HS 30032012).
Institutional or bulk-quantity medicines utilizing ceftazidime as the active antibiotic component are traded without measured retail packaging.
India, Vietnam and Pakistan together account for 39% of the published total, out of 24 trading partners on record.
Annual exports grew by 48% between 2021 and 2025, from $19.5M to $28.7M.
Figures come from official China General Administration of Customs (GACC) statistics, published monthly. ChinaData cleans partner names, periods and values so the series is ready for analysis. Partner-level rows for every month, including HS8 detail, are available on request.